DrugCite
Search

CEFTRIAXONE

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Ceftriaxone Adverse Events Reported to the FDA Over Time

How are Ceftriaxone adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Ceftriaxone, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Ceftriaxone is flagged as the suspect drug causing the adverse event.

Most Common Ceftriaxone Adverse Events Reported to the FDA

What are the most common Ceftriaxone adverse events reported to the FDA?

Pyrexia
423 (1.81%)
Renal Failure Acute
375 (1.61%)
Rash
311 (1.33%)
Dyspnoea
266 (1.14%)
Pruritus
229 (.98%)
Anaphylactic Shock
224 (.96%)
Toxic Epidermal Necrolysis
219 (.94%)
Thrombocytopenia
217 (.93%)
Renal Failure
204 (.87%)
Drug Rash With Eosinophilia And Sys...
200 (.86%)
Urticaria
184 (.79%)
Show More Show More
Cholelithiasis
179 (.77%)
Hypotension
175 (.75%)
Stevens-johnson Syndrome
171 (.73%)
Erythema
167 (.72%)
Vomiting
163 (.7%)
Diarrhoea
157 (.67%)
Nausea
138 (.59%)
Pneumonia
135 (.58%)
Drug Interaction
133 (.57%)
Sepsis
133 (.57%)
Cardiac Arrest
127 (.54%)
Anaphylactic Reaction
125 (.54%)
Hypersensitivity
123 (.53%)
Pancytopenia
121 (.52%)
Acute Respiratory Distress Syndrome
119 (.51%)
Abdominal Pain
117 (.5%)
Respiratory Failure
116 (.5%)
Confusional State
114 (.49%)
Multi-organ Failure
114 (.49%)
Alanine Aminotransferase Increased
112 (.48%)
Anaemia
112 (.48%)
Cytolytic Hepatitis
110 (.47%)
Eosinophilia
110 (.47%)
Rash Maculo-papular
110 (.47%)
Tachycardia
110 (.47%)
Condition Aggravated
105 (.45%)
Shock
105 (.45%)
Aspartate Aminotransferase Increase...
104 (.45%)
Neutropenia
104 (.45%)
Liver Disorder
103 (.44%)
General Physical Health Deteriorati...
100 (.43%)
International Normalised Ratio Incr...
100 (.43%)
Blood Creatinine Increased
98 (.42%)
Convulsion
97 (.42%)
Death
95 (.41%)
Septic Shock
94 (.4%)
Agranulocytosis
92 (.39%)
Cholestasis
90 (.39%)
Drug Hypersensitivity
90 (.39%)
Clostridium Difficile Colitis
88 (.38%)
Disseminated Intravascular Coagulat...
88 (.38%)
Gamma-glutamyltransferase Increased
85 (.36%)
Haemolysis
84 (.36%)
Blood Pressure Decreased
83 (.36%)
Chills
81 (.35%)
Dehydration
80 (.34%)
Haemoglobin Decreased
79 (.34%)
Dermatitis Exfoliative
78 (.33%)
Headache
78 (.33%)
Cough
77 (.33%)
Drug Eruption
77 (.33%)
Haemolytic Anaemia
77 (.33%)
Oedema Peripheral
73 (.31%)
Rash Erythematous
73 (.31%)
Acute Generalised Exanthematous Pus...
72 (.31%)
Blood Alkaline Phosphatase Increase...
72 (.31%)
Asthenia
71 (.3%)
Hepatitis
71 (.3%)
Toxic Skin Eruption
71 (.3%)
Drug Ineffective
70 (.3%)
Loss Of Consciousness
70 (.3%)
Erythema Multiforme
69 (.3%)
Malaise
69 (.3%)
Leukopenia
68 (.29%)
Tremor
68 (.29%)
Cardio-respiratory Arrest
65 (.28%)
Dermatitis Bullous
65 (.28%)
Platelet Count Decreased
65 (.28%)
Blister
64 (.27%)
Coma
64 (.27%)
Dizziness
64 (.27%)
Arthralgia
63 (.27%)
Oedema
63 (.27%)
Skin Exfoliation
63 (.27%)
Hepatic Function Abnormal
61 (.26%)
Pain
61 (.26%)
Pancreatitis
61 (.26%)
Cardiac Failure
60 (.26%)
Agitation
59 (.25%)
Altered State Of Consciousness
59 (.25%)
Depressed Level Of Consciousness
59 (.25%)
Rash Generalised
59 (.25%)
Respiratory Distress
59 (.25%)
Gastrointestinal Haemorrhage
58 (.25%)
Pleural Effusion
58 (.25%)
Somnolence
58 (.25%)
Hyperhidrosis
56 (.24%)
Inflammation
56 (.24%)
Overdose
56 (.24%)
Hypoglycaemia
54 (.23%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Ceftriaxone, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Ceftriaxone is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Ceftriaxone

What are the most common Ceftriaxone adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Ceftriaxone, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Ceftriaxone is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Ceftriaxone According to Those Reporting Adverse Events

Why are people taking Ceftriaxone, according to those reporting adverse events to the FDA?

Drug Use For Unknown Indication
868
Pneumonia
749
Product Used For Unknown Indication
495
Infection
311
Urinary Tract Infection
299
Pyrexia
219
Show More Show More
Bronchitis
197
Sepsis
157
Meningitis
116
Pyelonephritis
111
Prophylaxis
111
Lung Disorder
91
Lyme Disease
89
Cellulitis
88
Infection Prophylaxis
79
Lung Infection
77
Bronchopneumonia
67
Bacterial Infection
52
Endocarditis
45
Sinusitis
45
Antibiotic Prophylaxis
42
Meningitis Bacterial
41
Brain Abscess
37
Pneumonia Aspiration
35
Tonsillitis
35
Respiratory Tract Infection
34
Ill-defined Disorder
34
Osteomyelitis
33
Upper Respiratory Tract Infection
32
Pyelonephritis Acute
32
Erysipelas
30
Prostatitis
30
Pneumonia Bacterial
28
Osteitis
28
Lower Respiratory Tract Infection
28
Antibiotic Therapy
27
Meningococcal Sepsis
26
Septic Shock
25
Chronic Obstructive Pulmonary Disea...
24
Bronchopneumopathy
24
Peritonitis
23
Appendicitis
22
Bacteraemia
22
Cystitis
22
Pneumonitis
21
Borrelia Infection
21
Whipples Disease
21
Arthritis Bacterial
19
Acute Tonsillitis
19
Meningitis Pneumococcal
18
Staphylococcal Infection
17

Drug Labels

LabelLabelerEffective
CeftriaxoneWest-ward Pharmaceutical Corp26-AUG-09
CeftriaxoneBAXTER HEALTHCARE CORPORATION22-FEB-10
CeftriaxoneBedford Laboratories30-MAR-10
CeftriaxoneBedford Laboratories30-MAR-10
Ceftriaxone SodiumApotex Corp.14-MAY-10
RocephinGenentech, Inc.02-DEC-10
RocephinGenentech, Inc.02-DEC-10
Ceftriaxone SodiumRebel Distributors Corp17-JAN-11
CeftriaxoneLUPIN PHARMACEUTICALS INC30-MAY-11
CeftriaxoneLUPIN PHARMACEUTICALS INC08-JUN-11
CeftriaxoneAPP Pharmaceuticals , LLC20-JUN-11
CeftriaxoneAPP Pharmaceuticals , LLC20-JUN-11
CeftriaxoneSagent Pharmaceuticals24-JUN-11
Ceftriaxone SodiumSandoz Inc04-AUG-11
Ceftriaxone SodiumSandoz Inc04-AUG-11
Ceftriaxone SodiumHospira, Inc04-AUG-11
Ceftriaxone SodiumHospira, Inc07-OCT-11
Ceftriaxone SodiumHospira, Inc07-OCT-11
Ceftriaxone SodiumHospira, Inc07-OCT-11
Ceftriaxone And DextroseB. Braun Medical Inc.16-NOV-11
CeftriaxoneBaxter Healthcare Corporation09-JAN-12
Ceftriaxone SodiumCardinal Health01-FEB-12
Ceftriaxone SodiumCardinal Health01-FEB-12
CeftriaxoneRebel Distributors Corp09-FEB-12
CeftriaxoneAPP Pharmaceuticals, LLC02-MAR-12
CeftriaxoneRebel Distributors Corp20-MAR-12
Ceftriaxone SodiumCardinal Health03-APR-12
Ceftriaxone SodiumCardinal Health03-APR-12
Ceftriaxone SodiumCardinal Health03-APR-12
Ceftriaxone SodiumCardinal Health03-APR-12
CeftriaxoneCardinal Health12-APR-12
Ceftriaxone SodiumCardinal Health23-APR-12
CeftriaxoneWockhardt Limited02-MAY-12
CeftriaxoneWockhardt USA LLC.02-MAY-12
CeftriaxoneWG Critical Care, LLC18-MAY-12
Ceftriaxone Sodium Physicians Total Care, Inc.01-JUN-12
Ceftriaxone SodiumSandoz Inc09-JUL-12
Ceftriaxone SodiumSandoz Inc09-JUL-12
Ceftriaxone SodiumHospira, Inc.31-AUG-12
CeftriaxoneCephazone Pharma LLC07-SEP-12
CeftriaxoneWest-ward Pharmaceutical Corp18-SEP-12
Ceftriaxone SodiumApotex Corporation24-SEP-12
Ceftriaxone SodiumApotex Corporation16-OCT-12
CeftriaxoneWG Critical Care, LLC01-JAN-13
CeftriaxoneAGILA SPECIALTIES PRIVATE LIMITED10-JAN-13
CeftriaxoneTeva Parenteral Medicines, Inc.29-JAN-13
CeftriaxoneSagent Pharmaceuticals04-MAR-13
CeftriaxoneCardinal Health18-APR-13
Ceftriaxone SodiumREMEDYREPACK INC. 06-MAY-13

Ceftriaxone Case Reports

What Ceftriaxone safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Ceftriaxone. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Ceftriaxone.